Tag: biotechnology
-
Crispr Diagnostics Company Launches with $35M Funding
Sherlock Biosciences Inc., a new enterprise offering medical diagnostics based on the genome-editing technology Crispr, is starting up with $35 million in seed financing.
-
FDA Chief Calls Teen Vaping an “Epidemic”
The commissioner of the Food and Drug Administration warned that the sharp rise in teen electronic cigarette use is an epidemic threatening the public health.
-
NIH Funding Nanodrugs to Prevent Opioid Addiction
A drug that invokes the immune system to block addictive effects of opioid pain drugs and heroin is in early development at Washington University in St. Louis.
-
Gates Supporting Infectious Antibody Discovery
The Bill and Melinda Gates Foundation is enlisting a company that discovers therapeutic antibodies to help researchers develop new drugs and vaccines for serious infectious diseases.
-
Microsoft, Biotech Partner on Gene, Cell Therapies
A biotechnology company in the U.K. and U.S. software maker Microsoft are collaborating on new processes to speed development of gene and cell therapies.
-
Trial Shows Engineered Plant Product Heals Wounds
A small-scale clinical trial shows synthetic human collagen derived from engineered tobacco plants promotes closure of lower-limb wounds, often difficult to heal.
-
Commentary – Scott Gottlieb’s Legacy
During his tenure, FDA issued a number of guidance documents outlining regulatory processes and practices that streamline reviews, yet are still dictated by scientific evidence.
-
Trial Testing Targeted Solid Tumor Immunotherapy
A clinical trial is underway testing the safety of a cancer therapy that harnesses the immune system, but also works only in the tumor to reduce adverse side effects.
-
Skin Bacteria Therapy Tested in Kids with Eczema
A clinical trial is underway testing a form of bacteria sprayed on the skin that oxidize ammonia as a treatment for atopic dermatitis, or eczema, in children and teens.
-
Biogen Acquires Gene Therapy Company in $800M Deal
A company developing treatments for inherited eye diseases that replace malfunctioning with healthy genes is being acquired by biotechnology company Biogen.